Categories Earnings, Other Industries

AngioDynamics stock plummets on Q1 earnings miss

AngioDynamics (ANGO) reported first quarter earnings of $0.16 per share, which missed analyst estimates. However, the medical device maker’s top line surpassed street consensus. Shares of the company were trading down 8% at 12:22 am ET.

The company reported flat revenues of $85.3 million over last year, hurt by 6% slump in oncology product sales, primarily due to a drop in sales from the radiofrequency ablation line. The company also had a one-time impact in the quarter due to its transition from Acculis to Solero product line.

On the geographic front, AngioDynamics continued last quarter’s trend with US sales dipping nearly 2% over prior year, and international sales growing 7% due to the increased adoption of its products. In the first quarter, the company also paid $12.7 million in lieu of the legal allegations faced with the Justice Department.

AngioDynamics first quarter 2019 earnings

Margins improved 380 basis points, touching 52.1% aided by the facility consolidation efforts and improvement in operations. However, free cash flow slipped to the negative territory of $9.5 million compared to a positive cash flow of $2.5 million last year, which remains a concern.

To beef up its oncology portfolio, AngioDynamics acquired RadiaDyne and BioSentry in the quarter, which is expected to boost its bottom line in the upcoming quarters. The company has paid $87 million as upfront consideration, while $43 million as part of earnouts in future.

AngioDynamics misses Street consensus, shares dip

As a result of the acquisitions, the medical device maker has revised upwards its fiscal 2019 sales outlook, which is expected to come in the range of $354-359 million over $344-349 million guided last quarter. However, adjusted earnings remain unchanged at $0.82-0.86 per share. Shares of the company have jumped above 35% over the last 12 months and up nearly 46% in 2018.

Most Popular

Does Unity Software (U) stock has more room to run?

Last month, the IPO market was in a full swing. IPOs of Snowflake (NYSE: SNOW) and JFROG (NASDAQ: FROG) had an impressive opening day in September, the former creating a

PepsiCo (PEP): Steady snacking habits amid pandemic drive strong quarter for beverage giant

PepsiCo Inc. (NASDAQ: PEP) beat market expectations on both revenue and earnings for the third quarter of 2020. The company saw the momentum continue in its snacks business while the

Does the virus-driven boom make Electronic Arts (EA) a good investment?

With more and more people turning to virtual entertainment sources, amid the virus-related movement restrictions, video game publishers like Electronic Arts (NASDAQ: EA) are witnessing unusually high demand. Not surprisingly,

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top